COYA - Coya Therapeutics, Inc. Common Stock

Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company is headquartered in Houston, Texas.

52W High

$10.24

52W Low

$4.65

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.27

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-6.21

EV/Revenue (<3 favorable)

177.37

P/S (TTM) (<3 favorable)

247.65

P/B (<3 favorable)

3.70

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

7.12%

Institutions (25–75% balanced)

27.02%

Shares Outstanding

16,725,100

Float

12,632,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

423,450

Gross Profit (TTM)

-12,615,070

EPS (TTM)

-1.24

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-39.20%

ROE (TTM) (>15% strong)

-0.64%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

-0.95

Momentum

Bearish momentum

Value

-0.0088

0.0269

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025